B.M.P. PHARMA TRAD (BMP.SG) (BMP) - Total Liabilities
Based on the latest financial reports, B.M.P. PHARMA TRAD (BMP.SG) (BMP) has total liabilities worth €4.49 Million EUR (≈ $5.25 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
B.M.P. PHARMA TRAD (BMP.SG) - Total Liabilities Trend (2013–2024)
This chart illustrates how B.M.P. PHARMA TRAD (BMP.SG)'s total liabilities have evolved over time, based on quarterly financial data. See B.M.P. PHARMA TRAD (BMP.SG) (BMP) net assets for net asset value and shareholders' equity analysis.
B.M.P. PHARMA TRAD (BMP.SG) Competitors by Total Liabilities
The table below lists competitors of B.M.P. PHARMA TRAD (BMP.SG) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sumit Woods Limited
NSE:SUMIT
|
India | Rs1.16 Billion |
|
Greencoat UK Wind PLC
LSE:UKW
|
UK | GBX1.80 Billion |
|
Veea Inc.
NASDAQ:VEEA
|
USA | $33.73 Million |
|
Adval Tech Holding AG
SW:ADVN
|
Switzerland | CHF44.93 Million |
|
BioXcel Therapeutics Inc
NASDAQ:BTAI
|
USA | $133.71 Million |
|
ED Invest S.A.
WAR:EDI
|
Poland | zł50.19 Million |
|
Santierul Naval Orsova SA
RO:SNO
|
Romania | RON30.58 Million |
|
Thai Film Industries Public Company Limited
BK:TFI
|
Thailand | ฿814.65 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down B.M.P. PHARMA TRAD (BMP.SG)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of B.M.P. PHARMA TRAD (BMP.SG).
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 53.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how B.M.P. PHARMA TRAD (BMP.SG)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for B.M.P. PHARMA TRAD (BMP.SG) (2013–2024)
The table below shows the annual total liabilities of B.M.P. PHARMA TRAD (BMP.SG) from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €4.49 Million ≈ $5.25 Million |
+30.72% |
| 2023-12-31 | €3.44 Million ≈ $4.02 Million |
+63.13% |
| 2022-12-31 | €2.11 Million ≈ $2.46 Million |
+73.94% |
| 2021-12-31 | €1.21 Million ≈ $1.42 Million |
+46.35% |
| 2020-12-31 | €828.00K ≈ $968.02K |
+79.55% |
| 2019-12-31 | €461.14K ≈ $539.13K |
+14.93% |
| 2018-12-31 | €401.23K ≈ $469.08K |
+2.59% |
| 2017-12-31 | €391.11K ≈ $457.25K |
+17.10% |
| 2016-12-31 | €333.99K ≈ $390.47K |
+36.32% |
| 2015-12-31 | €245.00K ≈ $286.43K |
+51.23% |
| 2014-12-31 | €162.00K ≈ $189.40K |
-13.83% |
| 2013-12-31 | €188.00K ≈ $219.79K |
-- |
About B.M.P. PHARMA TRAD (BMP.SG)
There is no Profile data available for BMP.SG.